Eli Lilly and Co - Company Profile
Powered by
All the data and insights you need on Eli Lilly and Co in one report.
$295
- Save hours of research time and resources with
our up-to-date Eli Lilly and Co Strategy Report
- Understand Eli Lilly and Co position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
View up-to-date information on Eli Lilly and Co’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.
Number of Deals
Deal Value ($M)
Latest Deals
Announced Date | Headline | Deal Type | Acquirers/Investors/Surviving Entity | Issuer/Partner/Target |
---|---|---|---|---|
11 Oct 2022 | Eli Lilly Enters into Licensing Agreement with Nimbus Therapeutics | Licensing Agreement |
Eli Lilly and Co
|
Nimbus Therapeutics LLC
|
06 Oct 2022 | Schrodinger Enters into Co-Development Agreement with with Eli Lilly | Partnership | - |
Eli Lilly and Co
Schrodinger Inc
|
14 Sep 2022 | Capstan Therapeutics Raises USD102 Million in Series A Financing | Venture Financing |
Polaris Partners LLC
RA Capital Management LP
Novartis Venture Fund
Vida Ventures LLC
Bristol-Myers Squibb Co
Pfizer Ventures LLC
Eli Lilly and Co
Orbimed Advisors LLC
Leaps by Bayer
Alexandria Venture Investments
|
Capstan Therapeutics Inc
|
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
06 Apr 2021 | Lorem ipsum dolor sit amet, consectetur adipiscing elit | Eiusmod Tempor | Exercitation cillum velit | Exercitation cillum velit Tempor |
Contact the team or request a demo to find out how our data can drive your business forward
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer